<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Trends Mol Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Trends Mol Med</journal-id>
<journal-title-group>
<journal-title>Trends in Molecular Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1471-4914</issn>
<issn pub-type="epub">1471-499X</issn>
<publisher>
<publisher-name>Elsevier Science Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30348609</article-id>
<article-id pub-id-type="pmc">6224363</article-id>
<article-id pub-id-type="publisher-id">S1471-4914(18)30180-1</article-id>
<article-id pub-id-type="doi">10.1016/j.molmed.2018.09.002</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Do Defective Immune System-Mediated Myelination Processes Increase Postpartum Psychosis Risk?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dazzan</surname>
<given-names>Paola</given-names>
</name>
<xref ref-type="aff" rid="aff0005">1</xref>
<xref ref-type="aff" rid="aff0010">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fusté</surname>
<given-names>Montserrat</given-names>
</name>
<xref ref-type="aff" rid="aff0005">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Davies</surname>
<given-names>William</given-names>
</name>
<email>daviesw4@cardiff.ac.uk</email>
<xref ref-type="aff" rid="aff0015">3</xref>
<xref ref-type="corresp" rid="cor0005">⁎</xref>
</contrib>
</contrib-group>
<aff id="aff0005"><label>1</label>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK</aff>
<aff id="aff0010"><label>2</label>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, London, UK</aff>
<aff id="aff0015"><label>3</label>Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Schools of Medicine and Psychology, Cardiff University, Cardiff, UK</aff>
<author-notes>
<corresp id="cor0005"><label>⁎</label>Correspondence: <email>daviesw4@cardiff.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>11</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
<pub-date pub-type="ppub">
<month>11</month>
<year>2018</year>
</pub-date>
<volume>24</volume>
<issue>11</issue>
<fpage>942</fpage>
<lpage>949</lpage>
<permissions>
<copyright-statement>© 2018 The Authors</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
</license>
</permissions>
<abstract id="abs0005">
<p>Postpartum (or puerperal) psychosis (PP) is a rare, severe psychiatric disorder that affects women shortly after childbirth; risk is particularly high in individuals with a history of bipolar disorder or PP, but the underlying pathophysiology remains poorly understood. Emerging evidence suggests that immune system (dys)function plays an important role in disorder onset. On the basis of new findings from clinical and animal model studies, we hypothesise that the abundance and/or activity of regulatory T cells, and the efficacy of consequent (re)myelination processes in the brain mediated by CCN proteins, is perturbed in PP; this pathway may be modulated by risk and protective/treatment factors for the disorder, and identifying abnormalities within it could signpost novel predictive biomarkers and therapeutic targets.</p>
</abstract>
<abstract abstract-type="author-highlights" id="abs0010">
<title>Highlights</title>
<p>Postpartum psychosis (PP) is a rare, severe psychiatric disorder affecting some women shortly after childbirth.</p>
<p>While the risk factors for PP are relatively well understood, our knowledge of the underlying pathophysiology is extremely poor; however, there is some evidence that immune system dysregulation may play a role.</p>
<p>A recent study has shown that regulatory T cells (Tregs) may promote remyelination via the CCN family of proteins.</p>
<p>Here, we argue, on the basis of emerging immunological, animal model, and neuroimaging findings, that PP risk may be elevated due to abnormalities in the Treg–CCN–(re)myelination axis and that risk and protective/treatment factors for the disorder may influence this axis.</p>
</abstract>
<kwd-group id="kwd0005">
<title>Keywords</title>
<kwd>bipolar disorder</kwd>
<kwd>CCN3</kwd>
<kwd>mouse model</kwd>
<kwd>multiple sclerosis</kwd>
<kwd>oligodendrocyte</kwd>
<kwd>regulatory T cell</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec0005">
<title>Symptoms and Pathophysiology of Postpartum Psychosis</title>
<p id="par0005">Postpartum psychosis (PP) is a severe psychiatric disorder affecting approximately one or two of every 1000 women shortly after childbirth (most often within 6 weeks); the main symptoms include hallucinations, delusions, cognitive disorganisation, and mood abnormalities <xref ref-type="bibr" rid="bib0005">[1]</xref>. PP risk is highly predictable, with a risk recently reported to be ∼35% for women with a history of either bipolar affective disorder or previous PP <xref ref-type="bibr" rid="bib0010">[2]</xref>. Although PP occurs concomitantly with the biological sequelae of childbirth, its neurobiological basis remains poorly understood.</p>
<p id="par0010">The most intensively studied biological changes in PP have been those that occur in maternal reproductive hormones shortly after childbirth; however, no differences in absolute levels of oestrogen or progesterone have been identified in women who develop an episode of PP <xref ref-type="bibr" rid="bib0015">3</xref>, <xref ref-type="bibr" rid="bib0020">4</xref>. A genetic liability to PP has also been suggested: a linkage study in women with bipolar affective PP implicated chromosomal regions 16p13 and 8q24 (regions previously associated with bipolar disorder vulnerability) <xref ref-type="bibr" rid="bib0025">[5]</xref>, while genetic association studies have provided suggestive, albeit inconclusive, evidence of risk variants within candidate genes involved in serotonergic, hormone-dependent, or stress-response pathways <xref ref-type="bibr" rid="bib0030">6</xref>, <xref ref-type="bibr" rid="bib0035">7</xref>, <xref ref-type="bibr" rid="bib0040">8</xref>.</p>
<p id="par0015">Key obstacles in identifying biological risk and protective factors for PP include low disorder prevalence, high between-patient symptom heterogeneity, lack of accessibility to patient brain tissue, and a historical lack of amenable model systems <xref ref-type="bibr" rid="bib0045">[9]</xref>. However, understanding the pathophysiology of PP is crucial for identifying both novel therapeutic targets (for more efficacious drugs with fewer adverse effects) and predictive biomarkers (for identification of the most ‘at risk’ women before, or during, pregnancy, thereby facilitating earlier, more individualised clinical interventions).</p>
<p id="par0020">Recent evidence has highlighted a potentially important role for the immune system in the onset of PP: women with the disorder have higher rates of autoimmune thyroid dysfunction and pre-eclampsia (considered a disease of immunological maternal-fetal incompatibility) <xref ref-type="bibr" rid="bib0005">1</xref>, <xref ref-type="bibr" rid="bib0050">10</xref>, and some cases of PP involve an autoimmune response against the <italic>N</italic>-methyl-<sc>d</sc>-aspartic acid receptor <xref ref-type="bibr" rid="bib0055">[11]</xref>. The link between PP pathophysiology and the immune system may not be surprising, given that immune system dysregulation, characterised by elevated levels of serum proinflammatory cytokines such as interleukin (IL)-6, IL-1, and tumour necrosis factor-α, and alterations in the expression of associated genes now features prominently in pathophysiological models of depression (including in the postpartum period) <xref ref-type="bibr" rid="bib0060">12</xref>, <xref ref-type="bibr" rid="bib0065">13</xref>, bipolar affective disorder <xref ref-type="bibr" rid="bib0070">[14]</xref>, and psychosis <xref ref-type="bibr" rid="bib0075">15</xref>, <xref ref-type="bibr" rid="bib0080">16</xref>.</p>
</sec>
<sec id="sec0010">
<title>Immune System Dysfunction and PP</title>
<p id="par0025">PP occurs at a time of naturally heightened immune responsiveness. In pregnancy, a predominant anti-inflammatory T helper (Th)2-type immunity (whereby Th2 cell activity, including cytokine expression, is favoured over that from Th1 cells), has been historically considered responsible for maternal tolerance toward fetal alloantigens to protect the foetus from maternal Th1 cell-mediated immunity and subsequent attack <xref ref-type="bibr" rid="bib0085">[17]</xref>. However, more recent models of immunity function in pregnancy also implicate other T cell types, including <bold>regulatory T cells</bold> (Tregs; see <xref ref-type="glossary" rid="glo0005">Glossary</xref>), cytotoxic natural killer (NK) cells, and Th17 cells <xref ref-type="bibr" rid="bib0090">18</xref>, <xref ref-type="bibr" rid="bib0095">19</xref>. Treg levels typically increase in late pregnancy and peak early in the postpartum period, to be followed by later depletion <xref ref-type="bibr" rid="bib0095">[19]</xref>. Not only may Treg cells be important for regulating immunity and mediating self-tolerance in pregnancy but also for moderating the course of autoimmune disorders during this period. For example, the proliferation of Tregs that occurs during pregnancy is thought to mitigate acute exacerbations of multiple sclerosis (MS), an immune system-mediated demyelinating disease <xref ref-type="bibr" rid="bib0100">[20]</xref>.</p>
<p id="par0030">Two recent studies have reported that women with PP have lower levels of Th1, Th17, and Tregs <xref ref-type="bibr" rid="bib0105">[21]</xref> and a lower proportion of naïve Tregs (but a higher proportion of memory Tregs) <xref ref-type="bibr" rid="bib0110">[22]</xref> than healthy postpartum women. These findings may reflect the disrupted function of one or more subpopulations of Tregs in this clinical group, although the mechanisms underlying group differences in T cell proportions, and their precise functional relevance, are currently unclear. In addition, women with PP have been reported to exhibit lower numbers of NK cells <xref ref-type="bibr" rid="bib0105">[21]</xref> but increased regulatory NK cells <xref ref-type="bibr" rid="bib0110">[22]</xref> that counterbalance the cytotoxic NK response and are suggestive of a possible defect in the immune restoration normally present in the postpartum period. Furthermore, women with PP show a reduction in numbers of dendritic cells <xref ref-type="bibr" rid="bib0110">[22]</xref>; these cells are known to secrete higher levels of IL-12 and IL-6 in MS by inducing proinflammatory Th1 and Th17 cells, and their reduced numbers in women with PP could theoretically result in the persistence of immunosuppressive cells in the postpartum period.</p>
<p id="par0035">Finally, monocyte and macrophage levels have also been found to be significantly higher in women with PP than in those without PP. Although Kumar and colleagues <xref ref-type="bibr" rid="bib0110">[22]</xref> found no difference in total monocyte numbers between women with PP and healthy postpartum women, their study did find lower levels of the non-classical monocyte subtype, which display inflammatory characteristics upon activation, in the former group. The parallel findings of higher blood levels of chemokine CCL2 (produced by monocytes during tissue infiltration) in women with PP, and of a robustly upregulated immune system-related gene expression profile in this clinical group, strongly support the relevance of monocyte alterations in this disorder <xref ref-type="bibr" rid="bib0105">[21]</xref>.</p>
<p id="par0040">Collectively, the above-mentioned data support a model for PP whereby an imbalance between proinflammatory and immunosuppressive cells of the immune system in the postpartum period may be strongly associated, possibly causally, with the development of the disorder. It remains to be established whether, and how, peripheral immune activation might affect the maternal brain processes that underlie PP onset. However, data relevant to the pathophysiology of MS and other psychiatric conditions, discussed in the subsequent sections, suggest that an influence on myelination processes is possible.</p>
</sec>
<sec id="sec0015">
<title>Myelination Processes in the Perinatal Period</title>
<p id="par0045">While gray and white matter abnormalities have been consistently reported in psychoses not related to the puerperium <xref ref-type="bibr" rid="bib0115">[23]</xref>, until very recently, brain structure had never been investigated in PP. To date, only one study (from our group) has systematically evaluated gray matter structure using magnetic resonance imaging in women at risk of PP <xref ref-type="bibr" rid="bib0120">[24]</xref>. In brief, this study found that ‘at risk’ women who developed PP had smaller volumes of the anterior cingulate, superior temporal, and parahippocampal gyri compared to women at risk who did not develop PP, a pattern of alterations resembling that often found in patients with psychoses not related to the puerperium. Using a different imaging sequence, we also showed in this sample that women at risk of PP have reduced myelin content in the temporal lobes and sublobar areas relative to healthy women <xref ref-type="bibr" rid="bib0125">[25]</xref>. A case report in which PP was associated with white matter pathology in the corpus callosum <xref ref-type="bibr" rid="bib0130">[26]</xref> adds further weight to a possible link between PP risk and abnormal myelination processes.</p>
<p id="par0050">Studying white matter structure using sufficiently sensitive methods may be particularly informative in the context of PP, given evidence that maternal brain structure and associated physiology change substantially during pregnancy and into the postpartum period <xref ref-type="bibr" rid="bib0135">27</xref>, <xref ref-type="bibr" rid="bib0140">28</xref> and that there are notable sex differences in white matter structure, both in healthy individuals and in those affected by psychosis <xref ref-type="bibr" rid="bib0145">29</xref>, <xref ref-type="bibr" rid="bib0150">30</xref>. Of relevance to our proposed model, pregnancy is a time of considerable change in women with MS and in animal models of the condition, whereby symptom severity and the number/size of active white matter lesions are reduced <xref ref-type="bibr" rid="bib0155">[31]</xref>; this may be explained by the hormonal changes that physiologically occur in pregnancy (notably changes in prolactin levels), which can stimulate the maternal central nervous system (CNS) to generate new myelinating <bold>oligodendrocytes</bold> and facilitate partial remyelination, even in the presence of immune activation <xref ref-type="bibr" rid="bib0160">[32]</xref>. We propose that the (re)myelination processes that occur during pregnancy and the postpartum period in MS patients (and possibly also in healthy individuals) are compromised in women at risk of PP; this may explain why bipolar disorder symptoms do not improve significantly during pregnancy <xref ref-type="bibr" rid="bib0165">33</xref>, <xref ref-type="bibr" rid="bib0170">34</xref>.</p>
</sec>
<sec id="sec0020">
<title>A New Hypothesis Reconciling Immune System Dysfunction and Myelination Abnormalities in PP</title>
<p id="par0055">The recent publication of a study examining the cellular and molecular underpinnings of MS prompted us to consider previously unexplored mechanisms that may contribute to PP vulnerability. This new study elegantly demonstrated that Tregs can promote oligodendrocyte differentiation and (re)myelination within the CNS independently of inflammatory processes via secretion of the protein CCN3 (also known as nephroblastoma-overexpressed protein, or NOV) <xref ref-type="bibr" rid="bib0175">[35]</xref>. This finding was of particular interest to us given that the <bold>CCN protein family</bold> member CCN3 had been suggested as a candidate mediator of PP risk by our work in a novel pharmacological mouse model <xref ref-type="bibr" rid="bib0180">[36]</xref>. In our model, <italic>Ccn3</italic> expression was upregulated in whole brain tissue from new mouse mothers acutely administered an inhibitor of steroid sulfatase (to mimic the putative PP risk factor maternal steroid sulfatase deficiency <xref ref-type="bibr" rid="bib0185">[37]</xref>); these mice exhibited abnormal postpartum anxiety-related and startle behaviours of possible relevance to PP. The behavioural abnormalities and the <italic>Ccn3</italic> overexpression in the mouse model could be attenuated through administration of the antipsychotic drug ziprasidone, supporting its face and predictive validity. The finding that manipulation of placental gene activity in mice gives rise to altered maternal behaviours and increased brain (hippocampal) <italic>Ccn3</italic> expression <xref ref-type="bibr" rid="bib0190">[38]</xref> further supports the notion of CCN3 as a mediator of postpartum psychopathology <xref ref-type="bibr" rid="bib0045">9</xref>, <xref ref-type="bibr" rid="bib0180">36</xref>.</p>
<p id="par0060">Our pharmacological model also revealed increased brain gene expression for putative CCN protein interactors, including the pro-depressant CCN2(CTGF) <xref ref-type="bibr" rid="bib0195">[39]</xref>, which may heterodimerise with CCN3 and exert antagonistic effects <xref ref-type="bibr" rid="bib0200">[40]</xref>, and the PP-relevant CCL2 protein <xref ref-type="bibr" rid="bib0180">36</xref>, <xref ref-type="bibr" rid="bib0205">41</xref>. CCN2 blocks oligodendrocyte differentiation to reduce myelination levels <xref ref-type="bibr" rid="bib0210">42</xref>, <xref ref-type="bibr" rid="bib0215">43</xref> while CCL2 (monocyte chemoattractant protein-1) can influence blood–brain barrier permeability <xref ref-type="bibr" rid="bib0220">[44]</xref> and mobilisation of oligodendrocyte progenitor cells <xref ref-type="bibr" rid="bib0225">[45]</xref>.</p>
<p id="par0065">The CCN3 protein is present in the extracellular matrix, the cytoplasm, and the nucleus, and is involved in many diverse cellular processes including cell adhesion, migration, proliferation, differentiation, and survival <xref ref-type="bibr" rid="bib0230">[46]</xref>; it possesses multiple functional characteristics that support its candidacy as a mediator of PP risk, and its associated gene is located within the candidate PP genetic risk locus at 8q24 <xref ref-type="bibr" rid="bib0045">9</xref>, <xref ref-type="bibr" rid="bib0180">36</xref>. In adult human brain, <italic>CCN</italic> gene family members, including <italic>CCN3</italic>, are highly expressed throughout the cortex and the limbic system <xref ref-type="bibr" rid="bib0230">[46]</xref>, and their expression in these, and other tissues, may be modulated by several PP-relevant molecules such as oestrogen, serotonin, cytokines, psychotomimetics, and the mood-stabilising drug lithium <xref ref-type="bibr" rid="bib0045">9</xref>, <xref ref-type="bibr" rid="bib0180">36</xref>.</p>
<p id="par0070">The intriguing findings described above, together with emerging knowledge of immune system and brain structural alterations in PP, have allowed us to generate a novel and testable evidence-based hypothesis regarding PP risk that reconciles these lines of evidence. Generally, we propose that women at risk of PP are more likely than healthy individuals to display abnormalities in the immune system–CCN family (and interactors)–(re)myelination axis and that disruption of this axis is a core pathophysiological feature of PP. Specifically, we propose that a perturbation in Treg abundance/activity in women at risk of PP may be associated with altered expression of the CCN3 protein in the brain and subsequently with reduced levels of myelination in cortical and limbic brain regions exhibiting the highest <italic>CCN3</italic> expression and/or with the greatest accessibility to Treg influx.</p>
</sec>
<sec id="sec0025">
<title>Modulation of the Treg–CCN3–Myelin Axis by Risk and Protective/Treatment Factors for PP</title>
<p id="par0075">If dysfunction of the aforementioned axis contributes significantly to PP pathophysiology, we might expect key risk and protective factors associated with the condition to impact upon it. Patients with bipolar disorder show consistent evidence for reduced numbers of circulating Tregs <xref ref-type="bibr" rid="bib0235">47</xref>, <xref ref-type="bibr" rid="bib0240">48</xref>, and this is correlated with white matter integrity across much of the brain <xref ref-type="bibr" rid="bib0245">[49]</xref>; the molecular mechanisms underlying this correlation are, as yet, undetermined. Similarly, patients with autoimmune thyroid diseases have been reported to exhibit reduced Treg numbers <xref ref-type="bibr" rid="bib0250">[50]</xref> or impaired Treg cell function <xref ref-type="bibr" rid="bib0255">[51]</xref>. There is convincing evidence that the thyroid system can affect myelination and neural connectivity processes <xref ref-type="bibr" rid="bib0260">[52]</xref>, and rodent work has demonstrated that CCN expression is regulated by the thyroid hormone triiodothyronine in brain cortex <xref ref-type="bibr" rid="bib0265">[53]</xref>. Pre-eclampsia is also associated with low levels of circulating Tregs in some cases <xref ref-type="bibr" rid="bib0270">[54]</xref>, with long-term white matter changes (notably in the temporal lobe, an area involved in the pathophysiology of psychosis <xref ref-type="bibr" rid="bib0275">55</xref>, <xref ref-type="bibr" rid="bib0280">56</xref>), and with perturbed expression of CCN family members (including CCN3) in placental tissue and serum <xref ref-type="bibr" rid="bib0285">[57]</xref>. Moreover, CCN3 has repeatedly been implicated as a risk factor for hypertension <xref ref-type="bibr" rid="bib0290">[58]</xref>, a core feature of pre-eclampsia.</p>
<p id="par0080">Interestingly, systemic kynurenine levels (associated with effects on Treg activity <xref ref-type="bibr" rid="bib0295">[59]</xref>) have been reported to be lower in women with PP than in healthy controls <xref ref-type="bibr" rid="bib0300">[60]</xref>, and reduced kynurenine levels in patients with bipolar disorder have been associated with impaired white matter integrity <xref ref-type="bibr" rid="bib0305">[61]</xref>. Furthermore, the fact that remyelination efficiency decreases with age <xref ref-type="bibr" rid="bib0310">[62]</xref> may feasibly explain the association between PP risk and older maternal age <xref ref-type="bibr" rid="bib0315">[63]</xref>.</p>
<p id="par0085">Mood-stabilising drugs such as lithium have been reported to enhance white matter integrity in adults with bipolar disorder <xref ref-type="bibr" rid="bib0320">64</xref>, <xref ref-type="bibr" rid="bib0325">65</xref>, most likely through stimulating (re)myelination-promoting molecular cascades in oligodendrocytes <xref ref-type="bibr" rid="bib0330">[66]</xref>. The effects of antipsychotic administration on white matter integrity appear inconsistent and are more poorly defined, but there is some evidence for enhanced myelination via effects on oligodendrocytes <xref ref-type="bibr" rid="bib0335">67</xref>, <xref ref-type="bibr" rid="bib0340">68</xref>. Finally, rates of PP are higher in non-smokers than in smokers with bipolar disorder <xref ref-type="bibr" rid="bib0345">[69]</xref>; this is interesting since smoking boosts numbers and/or function of Tregs in the large airways and lungs (and possibly other tissues) <xref ref-type="bibr" rid="bib0350">70</xref>, <xref ref-type="bibr" rid="bib0355">71</xref> and reduces <italic>Ccn3</italic> expression in these tissues in a model system <xref ref-type="bibr" rid="bib0360">[72]</xref>.</p>
</sec>
<sec id="sec0030">
<title>Limitations of the Hypothesis</title>
<p id="par0090">Some important limitations to this proposed new hypothesis should be considered. First, the immunological, neuroimaging, and animal model findings upon which the hypothesis is founded are provisional and have yet to be replicated and fully characterised. Moreover, to date, it has been challenging to examine links between subtly aberrant de- or remyelination processes and vulnerability to general psychoses due to technical and practical limitations; with the advent of techniques with improved reliability and sensitivity, it should be possible to address more effectively how the former might influence the latter <xref ref-type="bibr" rid="bib0365">[73]</xref>. Second, other studies in women with PP or using alternative experimental models have not yet provided evidence for our hypothesis, although they have not refuted it. For example, early results from genome-wide association studies in PP have not identified dysfunctional T cell, CCN-related, or myelination pathways; however, this ‘absence of evidence’ should be viewed in light of the fact that these genetic studies are currently significantly underpowered <xref ref-type="bibr" rid="bib0045">[9]</xref>. Similarly, genetic and gene expression data from another animal model for PP, the infanticidal sow pig, have not strongly highlighted these pathways, although altered brain expression of myelin basic protein (MBP), prolactin, and the antipsychotic-target dopamine receptor D2 was noted in this model <xref ref-type="bibr" rid="bib0370">[74]</xref>; this lack of convergence could be explained by the fact that gene expression was only examined in a single brain region (the hypothalamus) involved in maternal behaviour, but not yet strongly implicated in PP pathophysiology <xref ref-type="bibr" rid="bib0045">[9]</xref>. An association analysis in the infanticidal sow pig highlighted <italic>PAX3</italic> as a candidate gene <xref ref-type="bibr" rid="bib0375">[75]</xref>; PAX3 may act as a transcriptional activator or repressor at the <italic>CCN3</italic>
<xref ref-type="bibr" rid="bib0380">[76]</xref> and <italic>MBP</italic>
<xref ref-type="bibr" rid="bib0385">[77]</xref> genes, respectively.</p>
<p id="par0095">Third, our hypothesis does not definitively identify the ‘postpartum trigger’. In a diathesis model, it is possible that dysregulation of the Treg–CCN3–myelination pathway confers trait vulnerability to PP and that the disorder then becomes manifest upon exposure to postpartum-specific factors, such as changes in hormone levels or environmental stressors. Alternatively, as studies aimed at understanding the molecular pathogenesis of bipolar disorder have not yet implicated CCN3 abnormalities, and as brain levels of CCN family proteins (and interactors) fluctuate considerably across mammalian pregnancy and the postpartum period <xref ref-type="bibr" rid="bib0390">[78]</xref>, it is plausible that it is specific abnormalities in the expression/function of these proteins that confer PP risk.</p>
<p id="par0100">Finally, it is unclear how Tregs may mediate myelination processes in the brain in women at risk, or with a history, of PP. Theoretically, this could be via secretion of factors such as CCN3 into the peripheral circulation and subsequent uptake into the brain. Alternatively, Tregs may percolate into the brain via a permeabilised blood–brain barrier (perhaps facilitated by increased CCL2 expression) and/or via the choroid plexus to affect function in the nearby limbic system <xref ref-type="bibr" rid="bib0395">[79]</xref>. While there is some evidence that Treg infiltration into the CNS may influence the presentation of MS (and possibly also bipolar disorder) <xref ref-type="bibr" rid="bib0245">49</xref>, <xref ref-type="bibr" rid="bib0395">79</xref>, to date there is no published information on the integrity of the blood–brain barrier in women with PP.</p>
</sec>
<sec id="sec0035">
<title>Concluding Remarks</title>
<p id="par0105">The precise mechanistic details by which Tregs might permeate the CNS, produce and secrete CCN3, and by which CCN3 may then influence oligodendrocyte-mediated (re)myelination processes remain to be clarified over the coming years. Identifying the effectors of these processes would allow a more focussed genetic, biochemical, and cellular investigation of the pathophysiology of PP. For example, genetic studies might focus upon specific candidate genes or pathways that are highlighted, negating the need for genome-wide multiple testing correction. A putative interactor with CCN3, discoidin domain receptor 1 (DDR1) <xref ref-type="bibr" rid="bib0400">[80]</xref>, may warrant further analysis in PP: intriguingly, this gene/protein is highly expressed in human CNS myelin where it co-localises with MBP <xref ref-type="bibr" rid="bib0405">[81]</xref>, is upregulated during oligodendrocyte-mediated (re)myelination <xref ref-type="bibr" rid="bib0410">[82]</xref>, and is associated with psychotic illness <xref ref-type="bibr" rid="bib0415">[83]</xref>. In the shorter term, clinical studies in women at risk of, or with, PP might focus on evaluating the number, proportion, and subtype of circulating Tregs; the frequency of genetic variants within <italic>CCN</italic> family and <italic>DDR1</italic> genes; levels of CCN3 (and CCN2) gene/protein expression in peripheral tissues such as serum, cerebrospinal fluid, and urine during pregnancy and the postpartum period; and the degree/integrity of myelination in relevant limbic and cortical structures.</p>
<p id="par0110">Our hypothesis may also be tested in more experimentally tractable systems, such as rodent models in which detailed measures of myelination can be obtained <italic>in vivo</italic> or postmortem using imaging and/or histological methods, respectively. In adult mice, Treg depletion in combination with exposure to environmental stressors results in phenotypes of relevance to PP (notably increased anxiety-related behaviours) together with decreased hippocampal serotonin levels <xref ref-type="bibr" rid="bib0420">[84]</xref>. We predict that Treg depletion and stressor exposure should elicit differential effects on maternal behaviour, <italic>Ccn3</italic> expression, hippocampal 5-hydroxytryptamine, and myelination levels in postpartum versus non-postpartum female mice, and versus control postpartum mice. Finally, gross manipulation of CCN3 levels <italic>in vivo</italic> (e.g., in knockout mice or in brain-overexpression models) or <italic>in vitro</italic> in mixed neuron–oligodendrocyte cell cultures may be associated with perturbed myelination and corresponding PP-relevant behavioural phenotypes. Likewise, in the pharmacological and genetic mouse models that display abnormal maternal behaviour and altered <italic>Ccn3</italic> expression <xref ref-type="bibr" rid="bib0045">9</xref>, <xref ref-type="bibr" rid="bib0180">36</xref>, <xref ref-type="bibr" rid="bib0190">38</xref>, we might expect subtle changes in myelination markers.</p>
<p id="par0115">We believe that the hypothesis described above provides a plausible and coherent central risk mechanism for PP, drawing together existing lines of evidence implicating risk and protective/treatment factors. The hypothesis makes specific and testable predictions across many clinical and experimental systems (see Outstanding Questions). Confirmation of abnormalities in the Treg–CCN3–myelin axis in PP might feasibly identify new avenues of treatment for PP (e.g., via modulation of Treg number/function <xref ref-type="bibr" rid="bib0425">[85]</xref> or CCN3 knockdown <xref ref-type="bibr" rid="bib0430">[86]</xref>), as well as novel predictive peripheral biomarkers (e.g., genetic polymorphisms, or perturbed peripheral CCN levels).</p>
<p id="par0120">Finally, our idea suggests that not only studies in inflammatory and autoimmune conditions previously associated with PP (e.g., pre-eclampsia and thyroid disorders) but also studies investigating immune conditions associated with aberrant (re)myelination and neuropsychiatric phenotypes such as MS might be informative for understanding PP pathophysiology; as such, a greater degree of collaboration between clinicians and scientists working within these areas is warranted.<boxed-text id="tb0005"><caption><title>Clinician’s Corner</title></caption><p id="par0125">Postpartum psychosis (PP) is a rare, severe, psychiatric disorder affecting some women shortly after childbirth; risk is known to be substantially elevated in women with a previous history of bipolar disorder, schizoaffective disorder, or PP, but the underlying pathophysiology is extremely poorly understood. Moreover, approximately half of the time, PP occurs in women with no previous psychiatric history.</p><p id="par0130">While the current treatments for PP are relatively efficacious, they do not target the cause of the disorder, they may be teratogenic if administered prophylactically during pregnancy, and they may have adverse side effects. There are currently no predictive markers available for PP; such markers would allow women at high risk to be identified early in pregnancy, thereby facilitating earlier, more individualised, and more effective clinical intervention.</p><p id="par0135">Here, we hypothesise, based upon emerging immunological, animal model, and neuroimaging data, that PP risk may be mediated by dysfunction of the regulatory T cell–CCN protein family–(re)myelination axis, a pathway that is also potentially aberrant in multiple sclerosis (MS); hence, we suggest that increased collaboration between clinicians and basic scientists studying PP and MS is warranted.</p><p id="par0140">The identification of abnormalities within the axis above in women at high risk of PP could ultimately allow the development of predictive biomarkers and more targeted treatment options with fewer side effects for this vulnerable group.</p></boxed-text><boxed-text id="tb0010"><label>Outstanding Questions</label><p id="par0145">How do regulatory T cell (sub)populations differ between women who have experienced an episode of postpartum psychosis (or who are at high risk) and mothers who have not?</p><p id="par0150">Does the sequence of <italic>CCN2</italic>, <italic>CCN3</italic>, and <italic>DDR1</italic> genes differ between women who have experienced an episode of postpartum psychosis (or who are at high risk) and mothers who have not?</p><p id="par0155">Does the peripheral expression of <italic>CCN2</italic>, <italic>CCN3</italic>, and <italic>DDR1</italic> genes (and their associated proteins) differ between women who have experienced an episode of postpartum psychosis (or who are at high risk) and mothers who have not?</p><p id="par0160">Do markers of (re)myelination efficacy differ between women who have experienced an episode of postpartum psychosis (or who are at high risk) and mothers who have not? If so, do these changes show any degree of regional specificity in the brain?</p><p id="par0165">To what extent do between-group differences in regulatory T cell populations, the CCN system, and myelination markers correlate with one another?</p><p id="par0170">Do animal and cellular models with experimental manipulations of regulatory T cell number/function and/or CCN expression exhibit anatomical, neurochemical, and behavioural features relevant to postpartum psychosis?</p><p id="par0175">Might a better understanding of the molecular pathways mediating immune system-mediated remyelination pathways allow for better postpartum psychosis risk prediction (e.g., in genetic analyses)?</p></boxed-text></p>
</sec>
</body>
<back>
<ref-list id="bibl0005">
<title>References</title>
<ref id="bib0005">
<label>1</label>
<element-citation id="sbref0005" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergink</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Postpartum psychosis: madness, mania, and melancholia in motherhood</article-title>
<source/>Am. J. Psychiatry
          <volume>173</volume>
<year>2016</year>
<fpage>1179</fpage>
<lpage>1188</lpage>
<pub-id pub-id-type="pmid">27609245</pub-id>
</element-citation>
</ref>
<ref id="bib0010">
<label>2</label>
<element-citation id="sbref0010" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wesseloo</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis</article-title>
<source/>Am. J. Psychiatry
          <volume>173</volume>
<year>2016</year>
<fpage>117</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="pmid">26514657</pub-id>
</element-citation>
</ref>
<ref id="bib0015">
<label>3</label>
<element-citation id="sbref0015" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Neuroendocrine and psychosocial mechanisms in post-partum psychosis</article-title>
<source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
          <volume>17</volume>
<year>1993</year>
<fpage>571</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="pmid">8362072</pub-id>
</element-citation>
</ref>
<ref id="bib0020">
<label>4</label>
<element-citation id="sbref0020" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wisner</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Stowe</surname>
<given-names>Z.N.</given-names>
</name>
</person-group>
<article-title>Psychobiology of postpartum mood disorders</article-title>
<source/>Semin. Reprod. Endocrinol.
          <volume>15</volume>
<year>1997</year>
<fpage>77</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="pmid">9065980</pub-id>
</element-citation>
</ref>
<ref id="bib0025">
<label>5</label>
<element-citation id="sbref0025" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Bipolar affective puerperal psychosis: genome-wide significant evidence for linkage to chromosome 16</article-title>
<source/>Am. J. Psychiatry
          <volume>164</volume>
<year>2007</year>
<fpage>1099</fpage>
<lpage>1104</lpage>
<pub-id pub-id-type="pmid">17606662</pub-id>
</element-citation>
</ref>
<ref id="bib0030">
<label>6</label>
<element-citation id="sbref0030" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period</article-title>
<source/>Lancet
          <volume>384</volume>
<year>2014</year>
<fpage>1789</fpage>
<lpage>1799</lpage>
<pub-id pub-id-type="pmid">25455249</pub-id>
</element-citation>
</ref>
<ref id="bib0035">
<label>7</label>
<element-citation id="sbref0035" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>H.B.</given-names>
</name>
</person-group>
<article-title>Serotonergic candidate genes and puerperal psychosis: an association study</article-title>
<source/>Psychiatr. Genet.
          <volume>17</volume>
<year>2007</year>
<fpage>253</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="pmid">17728663</pub-id>
</element-citation>
</ref>
<ref id="bib0040">
<label>8</label>
<element-citation id="sbref0040" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thippeswamy</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Estrogen pathway related genes and their association with risk of postpartum psychosis: a case control study</article-title>
<source/>Asian J. Psychiatry
          <volume>26</volume>
<year>2017</year>
<fpage>82</fpage>
<lpage>85</lpage>
</element-citation>
</ref>
<ref id="bib0045">
<label>9</label>
<element-citation id="sbref0045" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Understanding the pathophysiology of postpartum psychosis: challenges and new approaches</article-title>
<source/>World J. Psychiatry
          <volume>7</volume>
<year>2017</year>
<fpage>77</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="pmid">28713685</pub-id>
</element-citation>
</ref>
<ref id="bib0050">
<label>10</label>
<element-citation id="sbref0050" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergink</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Pre-eclampsia and first-onset postpartum psychiatric episodes: a Danish population-based cohort study</article-title>
<source/>Psychol. Med.
          <volume>45</volume>
<year>2015</year>
<fpage>3481</fpage>
<lpage>3489</lpage>
<pub-id pub-id-type="pmid">26243040</pub-id>
</element-citation>
</ref>
<ref id="bib0055">
<label>11</label>
<element-citation id="sbref0055" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergink</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Autoimmune encephalitis in postpartum psychosis</article-title>
<source/>Am. J. Psychiatry
          <volume>172</volume>
<year>2015</year>
<fpage>901</fpage>
<lpage>908</lpage>
<pub-id pub-id-type="pmid">26183699</pub-id>
</element-citation>
</ref>
<ref id="bib0060">
<label>12</label>
<element-citation id="sbref0060" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boufidou</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>CSF and plasma cytokines at delivery and postpartum mood disturbances</article-title>
<source/>J. Affect. Disord.
          <volume>115</volume>
<year>2009</year>
<fpage>287</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="pmid">18708264</pub-id>
</element-citation>
</ref>
<ref id="bib0065">
<label>13</label>
<element-citation id="sbref0065" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohler</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies</article-title>
<source/>Acta Psychiatr. Scand.
          <volume>135</volume>
<year>2017</year>
<fpage>373</fpage>
<lpage>387</lpage>
<pub-id pub-id-type="pmid">28122130</pub-id>
</element-citation>
</ref>
<ref id="bib0070">
<label>14</label>
<element-citation id="sbref0070" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drexhage</surname>
<given-names>R.C.</given-names>
</name>
</person-group>
<article-title>Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients</article-title>
<source/>Int. J. Neuropsychopharmacol.
          <volume>13</volume>
<year>2010</year>
<fpage>1369</fpage>
<lpage>1381</lpage>
<pub-id pub-id-type="pmid">20633309</pub-id>
</element-citation>
</ref>
<ref id="bib0075">
<label>15</label>
<element-citation id="sbref0075" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergink</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Autoimmunity, inflammation, and psychosis: a search for peripheral markers</article-title>
<source/>Biol. Psychiatry
          <volume>75</volume>
<year>2014</year>
<fpage>324</fpage>
<lpage>331</lpage>
<pub-id pub-id-type="pmid">24286760</pub-id>
</element-citation>
</ref>
<ref id="bib0080">
<label>16</label>
<element-citation id="sbref0080" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects</article-title>
<source/>Biol. Psychiatry
          <volume>70</volume>
<year>2011</year>
<fpage>663</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="pmid">21641581</pub-id>
</element-citation>
</ref>
<ref id="bib0085">
<label>17</label>
<element-citation id="sbref0085" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mor</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Inflammation and pregnancy: the role of the immune system at the implantation site</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <volume>1221</volume>
<year>2011</year>
<fpage>80</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="pmid">21401634</pub-id>
</element-citation>
</ref>
<ref id="bib0090">
<label>18</label>
<element-citation id="sbref0090" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kraus</surname>
<given-names>T.A.</given-names>
</name>
</person-group>
<article-title>Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study</article-title>
<source/>J. Clin. Immunol.
          <volume>32</volume>
<year>2012</year>
<fpage>300</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="pmid">22198680</pub-id>
</element-citation>
</ref>
<ref id="bib0095">
<label>19</label>
<element-citation id="sbref0095" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wegienka</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Within-woman change in regulatory T cells from pregnancy to the postpartum period</article-title>
<source/>J. Reprod. Immunol.
          <volume>88</volume>
<year>2011</year>
<fpage>58</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">20961621</pub-id>
</element-citation>
</ref>
<ref id="bib0100">
<label>20</label>
<element-citation id="sbref0100" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iorio</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis</article-title>
<source/>Clin. Immunol.
          <volume>131</volume>
<year>2009</year>
<fpage>70</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">19097824</pub-id>
</element-citation>
</ref>
<ref id="bib0105">
<label>21</label>
<element-citation id="sbref0105" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergink</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Immune system dysregulation in first-onset postpartum psychosis</article-title>
<source/>Biol. Psychiatry
          <volume>73</volume>
<year>2013</year>
<fpage>1000</fpage>
<lpage>1007</lpage>
<pub-id pub-id-type="pmid">23270599</pub-id>
</element-citation>
</ref>
<ref id="bib0110">
<label>22</label>
<element-citation id="sbref0110" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Immune system aberrations in postpartum psychosis: an immunophenotyping study from a tertiary care neuropsychiatric hospital in India</article-title>
<source/>J. Neuroimmunol.
          <volume>310</volume>
<year>2017</year>
<fpage>8</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">28778450</pub-id>
</element-citation>
</ref>
<ref id="bib0115">
<label>23</label>
<element-citation id="sbref0115" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Peri</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies</article-title>
<source/>Curr. Pharm. Des.
          <volume>18</volume>
<year>2012</year>
<fpage>486</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="pmid">22239579</pub-id>
</element-citation>
</ref>
<ref id="bib0120">
<label>24</label>
<element-citation id="sbref0120" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuste</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Brain structure in women at risk of postpartum psychosis: an MRI study</article-title>
<source/>Transl. Psychiatry
          <volume>7</volume>
<year>2017</year>
<fpage>1286</fpage>
<lpage>1294</lpage>
<pub-id pub-id-type="pmid">29249808</pub-id>
</element-citation>
</ref>
<ref id="bib0125">
<label>25</label>
<element-citation id="sbref0125" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giordano</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>SA86. Neuroinflammation in puerperal psychosis: the relationship between myelin content and peripheral inflammatory markers</article-title>
<source/>Schizophr. Bull.
          <volume>43</volume>
<year>2017</year>
<fpage>S144</fpage>
</element-citation>
</ref>
<ref id="bib0130">
<label>26</label>
<element-citation id="sbref0130" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Udaya</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Bright splenium of a psychotic mind</article-title>
<source/>Ann. Indian Acad. Neurol.
          <volume>18</volume>
<year>2015</year>
<fpage>80</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">25745318</pub-id>
</element-citation>
</ref>
<ref id="bib0135">
<label>27</label>
<element-citation id="sbref0135" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoekzema</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Pregnancy leads to long-lasting changes in human brain structure</article-title>
<source/>Nat. Neurosci.
          <volume>20</volume>
<year>2017</year>
<fpage>287</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="pmid">27991897</pub-id>
</element-citation>
</ref>
<ref id="bib0140">
<label>28</label>
<element-citation id="sbref0140" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The plasticity of human maternal brain: longitudinal changes in brain anatomy during the early postpartum period</article-title>
<source/>Behav. Neurosci.
          <volume>124</volume>
<year>2010</year>
<fpage>695</fpage>
<lpage>700</lpage>
<pub-id pub-id-type="pmid">20939669</pub-id>
</element-citation>
</ref>
<ref id="bib0145">
<label>29</label>
<element-citation id="sbref0145" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cosgrove</surname>
<given-names>K.P.</given-names>
</name>
</person-group>
<article-title>Evolving knowledge of sex differences in brain structure, function, and chemistry</article-title>
<source/>Biol. Psychiatry
          <volume>62</volume>
<year>2007</year>
<fpage>847</fpage>
<lpage>855</lpage>
<pub-id pub-id-type="pmid">17544382</pub-id>
</element-citation>
</ref>
<ref id="bib0150">
<label>30</label>
<element-citation id="sbref0150" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Domen</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Microstructural white matter alterations in psychotic disorder: a family-based diffusion tensor imaging study</article-title>
<source/>Schizophr. Res.
          <volume>146</volume>
<year>2013</year>
<fpage>291</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="pmid">23523694</pub-id>
</element-citation>
</ref>
<ref id="bib0155">
<label>31</label>
<element-citation id="sbref0155" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voskuhl</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Momtazee</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Pregnancy: effect on multiple sclerosis, treatment considerations, and breastfeeding</article-title>
<source/>Neurotherapeutics
          <volume>14</volume>
<year>2017</year>
<fpage>974</fpage>
<lpage>984</lpage>
<pub-id pub-id-type="pmid">28766273</pub-id>
</element-citation>
</ref>
<ref id="bib0160">
<label>32</label>
<element-citation id="sbref0160" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregg</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Pregnancy, prolactin and white matter regeneration</article-title>
<source/>J. Neurol. Sci.
          <volume>285</volume>
<year>2009</year>
<fpage>22</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">19608204</pub-id>
</element-citation>
</ref>
<ref id="bib0165">
<label>33</label>
<element-citation id="sbref0165" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Driscoll</surname>
<given-names>K.E.</given-names>
</name>
</person-group>
<article-title>Mood symptoms in pregnant and postpartum women with bipolar disorder: a naturalistic study</article-title>
<source/>Bipolar Disord.
          <volume>19</volume>
<year>2017</year>
<fpage>295</fpage>
<lpage>304</lpage>
<pub-id pub-id-type="pmid">28665044</pub-id>
</element-citation>
</ref>
<ref id="bib0170">
<label>34</label>
<element-citation id="sbref0170" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergink</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Prevention of postpartum psychosis and mania in women at high risk</article-title>
<source/>Am. J. Psychiatry
          <volume>169</volume>
<year>2012</year>
<fpage>609</fpage>
<lpage>615</lpage>
<pub-id pub-id-type="pmid">22407083</pub-id>
</element-citation>
</ref>
<ref id="bib0175">
<label>35</label>
<element-citation id="sbref0175" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dombrowski</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Regulatory T cells promote myelin regeneration in the central nervous system</article-title>
<source/>Nat. Neurosci.
          <volume>20</volume>
<year>2017</year>
<fpage>674</fpage>
<lpage>680</lpage>
<pub-id pub-id-type="pmid">28288125</pub-id>
</element-citation>
</ref>
<ref id="bib0180">
<label>36</label>
<element-citation id="sbref0180" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Humby</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>A pharmacological mouse model suggests a novel risk pathway for postpartum psychosis</article-title>
<source/>Psychoneuroendocrinology
          <volume>74</volume>
<year>2016</year>
<fpage>363</fpage>
<lpage>370</lpage>
<pub-id pub-id-type="pmid">27728876</pub-id>
</element-citation>
</ref>
<ref id="bib0185">
<label>37</label>
<element-citation id="sbref0185" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Does steroid sulfatase deficiency influence postpartum psychosis risk?</article-title>
<source/>Trends Mol. Med.
          <volume>18</volume>
<year>2012</year>
<fpage>256</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="pmid">22475435</pub-id>
</element-citation>
</ref>
<ref id="bib0190">
<label>38</label>
<element-citation id="sbref0190" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Creeth</surname>
<given-names>H.D.J.</given-names>
</name>
</person-group>
<article-title>Maternal care boosted by paternal imprinting in mammals</article-title>
<source/>PLoS Biol.
          <volume>16</volume>
<year>2018</year>
<object-id pub-id-type="publisher-id">e2006599</object-id>
</element-citation>
</ref>
<ref id="bib0195">
<label>39</label>
<element-citation id="sbref0195" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Connective tissue growth factor is a novel prodepressant</article-title>
<source/>Biol. Psychiatry
          <volume>84</volume>
<year>2018</year>
<fpage>555</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="pmid">29861095</pub-id>
</element-citation>
</ref>
<ref id="bib0200">
<label>40</label>
<element-citation id="sbref0200" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoshijima</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Roles of heterotypic CCN2/CTGF-CCN3/NOV and homotypic CCN2-CCN2 interactions in expression of the differentiated phenotype of chondrocytes</article-title>
<source/>FEBS J.
          <volume>279</volume>
<year>2012</year>
<fpage>3584</fpage>
<lpage>3597</lpage>
<pub-id pub-id-type="pmid">22812570</pub-id>
</element-citation>
</ref>
<ref id="bib0205">
<label>41</label>
<element-citation id="sbref0205" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Dreau</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>NOV/CCN3 upregulates CCL2 and CXCL1 expression in astrocytes through beta1 and beta5 integrins</article-title>
<source/>Glia
          <volume>58</volume>
<year>2010</year>
<fpage>1510</fpage>
<lpage>1521</lpage>
<pub-id pub-id-type="pmid">20648642</pub-id>
</element-citation>
</ref>
<ref id="bib0210">
<label>42</label>
<element-citation id="sbref0210" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ercan</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex</article-title>
<source/>J. Exp. Med.
          <volume>214</volume>
<year>2017</year>
<fpage>681</fpage>
<lpage>697</lpage>
<pub-id pub-id-type="pmid">28183733</pub-id>
</element-citation>
</ref>
<ref id="bib0215">
<label>43</label>
<element-citation id="sbref0215" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamond</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Barnett</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Schwann cells but not olfactory ensheathing cells inhibit CNS myelination via the secretion of connective tissue growth factor</article-title>
<source/>J. Neurosci.
          <volume>33</volume>
<year>2013</year>
<fpage>18686</fpage>
<lpage>18697</lpage>
<pub-id pub-id-type="pmid">24259589</pub-id>
</element-citation>
</ref>
<ref id="bib0220">
<label>44</label>
<element-citation id="sbref0220" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yadav</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>MCP-1: chemoattractant with a role beyond immunity: a review</article-title>
<source/>Clin. Chim. Acta
          <volume>411</volume>
<year>2010</year>
<fpage>1570</fpage>
<lpage>1579</lpage>
<pub-id pub-id-type="pmid">20633546</pub-id>
</element-citation>
</ref>
<ref id="bib0225">
<label>45</label>
<element-citation id="sbref0225" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moyon</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration</article-title>
<source/>J. Neurosci.
          <volume>35</volume>
<year>2015</year>
<fpage>4</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">25568099</pub-id>
</element-citation>
</ref>
<ref id="bib0230">
<label>46</label>
<element-citation id="sbref0230" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malik</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Matricellular proteins of the Cyr61/CTGF/NOV (CCN) family and the nervous system</article-title>
<source/>Front. Cell. Neurosci.
          <volume>9</volume>
<year>2015</year>
<fpage>237</fpage>
<pub-id pub-id-type="pmid">26157362</pub-id>
</element-citation>
</ref>
<ref id="bib0235">
<label>47</label>
<element-citation id="sbref0235" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>do Prado</surname>
<given-names>C.H.</given-names>
</name>
</person-group>
<article-title>Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder</article-title>
<source/>Psychoneuroendocrinology
          <volume>38</volume>
<year>2013</year>
<fpage>667</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="pmid">22989476</pub-id>
</element-citation>
</ref>
<ref id="bib0240">
<label>48</label>
<element-citation id="sbref0240" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vogels</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>T cell deficits and overexpression of hepatocyte growth factor in anti-inflammatory circulating monocytes of middle-aged patients with bipolar disorder characterized by a high prevalence of the metabolic syndrome</article-title>
<source/>Front. Psychiatry
          <volume>8</volume>
<year>2017</year>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">28167920</pub-id>
</element-citation>
</ref>
<ref id="bib0245">
<label>49</label>
<element-citation id="sbref0245" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poletti</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Th17 cells correlate positively to the structural and functional integrity of the brain in bipolar depression and healthy controls</article-title>
<source/>Brain Behav. Immun.
          <volume>61</volume>
<year>2017</year>
<fpage>317</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="pmid">28025071</pub-id>
</element-citation>
</ref>
<ref id="bib0250">
<label>50</label>
<element-citation id="sbref0250" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Imbalance of Th17/Treg in different subtypes of autoimmune thyroid diseases</article-title>
<source/>Cell. Physiol. Biochem.
          <volume>40</volume>
<year>2016</year>
<fpage>245</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="pmid">27855396</pub-id>
</element-citation>
</ref>
<ref id="bib0255">
<label>51</label>
<element-citation id="sbref0255" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glick</surname>
<given-names>A.B.</given-names>
</name>
</person-group>
<article-title>Impairment of regulatory T-cell function in autoimmune thyroid disease</article-title>
<source/>Thyroid
          <volume>23</volume>
<year>2013</year>
<fpage>871</fpage>
<lpage>878</lpage>
<pub-id pub-id-type="pmid">23379353</pub-id>
</element-citation>
</ref>
<ref id="bib0260">
<label>52</label>
<element-citation id="sbref0260" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calza</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Role of the thyroid system in myelination and neural connectivity</article-title>
<source/>Compr. Physiol.
          <volume>5</volume>
<year>2015</year>
<fpage>1405</fpage>
<lpage>1421</lpage>
<pub-id pub-id-type="pmid">26140723</pub-id>
</element-citation>
</ref>
<ref id="bib0265">
<label>53</label>
<element-citation id="sbref0265" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berbel</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>An evo-devo approach to thyroid hormones in cerebral and cerebellar cortical development: etiological implications for autism</article-title>
<source/>Front. Endocrinol. (Lausanne)
          <volume>5</volume>
<year>2014</year>
<fpage>1</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="pmid">24474947</pub-id>
</element-citation>
</ref>
<ref id="bib0270">
<label>54</label>
<element-citation id="sbref0270" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahimzadeh</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Regulatory T-cells and preeclampsia: an overview of literature</article-title>
<source/>Expert Rev. Clin. Immunol.
          <volume>12</volume>
<year>2016</year>
<fpage>209</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="pmid">26580672</pub-id>
</element-citation>
</ref>
<ref id="bib0275">
<label>55</label>
<element-citation id="sbref0275" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siepmann</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Long-term cerebral white and gray matter changes after preeclampsia</article-title>
<source/>Neurology
          <volume>88</volume>
<year>2017</year>
<fpage>1256</fpage>
<lpage>1264</lpage>
<pub-id pub-id-type="pmid">28235810</pub-id>
</element-citation>
</ref>
<ref id="bib0280">
<label>56</label>
<element-citation id="sbref0280" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiegman</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Regional distribution of cerebral white matter lesions years after preeclampsia and eclampsia</article-title>
<source/>Obstet. Gynecol.
          <volume>123</volume>
<year>2014</year>
<fpage>790</fpage>
<lpage>795</lpage>
<pub-id pub-id-type="pmid">24785606</pub-id>
</element-citation>
</ref>
<ref id="bib0285">
<label>57</label>
<element-citation id="sbref0285" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winterhager</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gellhaus</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The role of the CCN family of proteins in female reproduction</article-title>
<source/>Cell. Mol. Life Sci.
          <volume>71</volume>
<year>2014</year>
<fpage>2299</fpage>
<lpage>2311</lpage>
<pub-id pub-id-type="pmid">24448904</pub-id>
</element-citation>
</ref>
<ref id="bib0290">
<label>58</label>
<element-citation id="sbref0290" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wain</surname>
<given-names>L.V.</given-names>
</name>
</person-group>
<article-title>Novel blood pressure locus and gene discovery using genome-wide association study and expression data sets from blood and the kidney</article-title>
<source/>Hypertension
          <volume>70</volume>
<year>2017</year>
<fpage>e4</fpage>
<lpage>e19</lpage>
</element-citation>
</ref>
<ref id="bib0295">
<label>59</label>
<element-citation id="sbref0295" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Vecsei</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The kynurenine system and immunoregulation</article-title>
<source/>J. Neural Transm. (Vienna)
          <volume>119</volume>
<year>2012</year>
<fpage>197</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="pmid">21744051</pub-id>
</element-citation>
</ref>
<ref id="bib0300">
<label>60</label>
<element-citation id="sbref0300" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veen</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression</article-title>
<source/>J. Affect. Disord.
          <volume>189</volume>
<year>2016</year>
<fpage>298</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="pmid">26454336</pub-id>
</element-citation>
</ref>
<ref id="bib0305">
<label>61</label>
<element-citation id="sbref0305" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poletti</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Kynurenine pathway and white matter microstructure in bipolar disorder</article-title>
<source/>Eur. Arch. Psychiatry Clin. Neurosci.
          <volume>268</volume>
<year>2018</year>
<fpage>157</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="pmid">27619930</pub-id>
</element-citation>
</ref>
<ref id="bib0310">
<label>62</label>
<element-citation id="sbref0310" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franklin</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Glia disease and repair-remyelination</article-title>
<source/>Cold Spring Harb. Perspect. Biol.
          <volume>7</volume>
<year>2015</year>
<fpage>1</fpage>
<lpage>28</lpage>
</element-citation>
</ref>
<ref id="bib0315">
<label>63</label>
<element-citation id="sbref0315" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valdimarsdottir</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Psychotic illness in first-time mothers with no previous psychiatric hospitalizations: a population-based study</article-title>
<source/>PLoS Med.
          <volume>6</volume>
<year>2009</year>
<fpage>194</fpage>
<lpage>201</lpage>
</element-citation>
</ref>
<ref id="bib0320">
<label>64</label>
<element-citation id="sbref0320" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benedetti</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Lithium and GSK3-beta promoter gene variants influence white matter microstructure in bipolar disorder</article-title>
<source/>Neuropsychopharmacology
          <volume>38</volume>
<year>2013</year>
<fpage>313</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="pmid">22990942</pub-id>
</element-citation>
</ref>
<ref id="bib0325">
<label>65</label>
<element-citation id="sbref0325" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gildengers</surname>
<given-names>A.G.</given-names>
</name>
</person-group>
<article-title>Longer lithium exposure is associated with better white matter integrity in older adults with bipolar disorder</article-title>
<source/>Bipolar Disord.
          <volume>17</volume>
<year>2015</year>
<fpage>248</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="pmid">25257942</pub-id>
</element-citation>
</ref>
<ref id="bib0330">
<label>66</label>
<element-citation id="sbref0330" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meffre</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Lithium chloride stimulates PLP and MBP expression in oligodendrocytes via Wnt/beta-catenin and Akt/CREB pathways</article-title>
<source/>Neuroscience
          <volume>284</volume>
<year>2015</year>
<fpage>962</fpage>
<lpage>971</lpage>
<pub-id pub-id-type="pmid">25451297</pub-id>
</element-citation>
</ref>
<ref id="bib0335">
<label>67</label>
<element-citation id="sbref0335" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartzokis</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments</article-title>
<source/>Front. Biosci. (Landmark Ed.)
          <volume>16</volume>
<year>2011</year>
<fpage>2695</fpage>
<lpage>2733</lpage>
<pub-id pub-id-type="pmid">21622204</pub-id>
</element-citation>
</ref>
<ref id="bib0340">
<label>68</label>
<element-citation id="sbref0340" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walterfang</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Understanding aberrant white matter development in schizophrenia: an avenue for therapy?</article-title>
<source/>Expert Rev. Neurother.
          <volume>11</volume>
<year>2011</year>
<fpage>971</fpage>
<lpage>987</lpage>
<pub-id pub-id-type="pmid">21721915</pub-id>
</element-citation>
</ref>
<ref id="bib0345">
<label>69</label>
<element-citation id="sbref0345" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Florio</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Smoking and postpartum psychosis</article-title>
<source/>Bipolar Disord.
          <volume>17</volume>
<year>2015</year>
<fpage>572</fpage>
<lpage>573</lpage>
<pub-id pub-id-type="pmid">26241192</pub-id>
</element-citation>
</ref>
<ref id="bib0350">
<label>70</label>
<element-citation id="sbref0350" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herberth</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Differential effects on T-cell function following exposure to serum from schizophrenia smokers</article-title>
<source/>Mol. Psychiatry
          <volume>15</volume>
<year>2010</year>
<fpage>364</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="pmid">19002140</pub-id>
</element-citation>
</ref>
<ref id="bib0355">
<label>71</label>
<element-citation id="sbref0355" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lane</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Regulation in chronic obstructive pulmonary disease: the role of regulatory T-cells and Th17 cells</article-title>
<source/>Clin. Sci. (Lond.)
          <volume>119</volume>
<year>2010</year>
<fpage>75</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">20402669</pub-id>
</element-citation>
</ref>
<ref id="bib0360">
<label>72</label>
<element-citation id="sbref0360" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gueugnon</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Altered expression of the CCN genes in the lungs of mice in response to cigarette smoke exposure and viral and bacterial infections</article-title>
<source/>Gene
          <volume>586</volume>
<year>2016</year>
<fpage>176</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="pmid">27080955</pub-id>
</element-citation>
</ref>
<ref id="bib0365">
<label>73</label>
<element-citation id="sbref0365" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mighdoll</surname>
<given-names>M.I.</given-names>
</name>
</person-group>
<article-title>Myelin, myelin-related disorders, and psychosis</article-title>
<source/>Schizophr. Res.
          <volume>161</volume>
<year>2015</year>
<fpage>85</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">25449713</pub-id>
</element-citation>
</ref>
<ref id="bib0370">
<label>74</label>
<element-citation id="sbref0370" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quilter</surname>
<given-names>C.R.</given-names>
</name>
</person-group>
<article-title>Gene expression profiling in porcine maternal infanticide: a model for puerperal psychosis</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
          <volume>147B</volume>
<year>2008</year>
<fpage>1126</fpage>
<lpage>1137</lpage>
<pub-id pub-id-type="pmid">18361432</pub-id>
</element-citation>
</ref>
<ref id="bib0375">
<label>75</label>
<element-citation id="sbref0375" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quilter</surname>
<given-names>C.R.</given-names>
</name>
</person-group>
<article-title>An association and haplotype analysis of porcine maternal infanticide: a model for human puerperal psychosis?</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
          <volume>159B</volume>
<year>2012</year>
<fpage>908</fpage>
<lpage>927</lpage>
<pub-id pub-id-type="pmid">22976950</pub-id>
</element-citation>
</ref>
<ref id="bib0380">
<label>76</label>
<element-citation id="sbref0380" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells</article-title>
<source/>Oncogene
          <volume>30</volume>
<year>2011</year>
<fpage>3549</fpage>
<lpage>3562</lpage>
<pub-id pub-id-type="pmid">21423212</pub-id>
</element-citation>
</ref>
<ref id="bib0385">
<label>77</label>
<element-citation id="sbref0385" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boudjadi</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The expression and function of PAX3 in development and disease</article-title>
<source/>Gene
          <volume>666</volume>
<year>2018</year>
<fpage>145</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="pmid">29730428</pub-id>
</element-citation>
</ref>
<ref id="bib0390">
<label>78</label>
<element-citation id="sbref0390" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>An examination of dynamic gene expression changes in the mouse brain during pregnancy and the postpartum period</article-title>
<source/>G3 (Bethesda)
          <volume>6</volume>
<year>2015</year>
<fpage>221</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="pmid">26596646</pub-id>
</element-citation>
</ref>
<ref id="bib0395">
<label>79</label>
<element-citation id="sbref0395" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sallusto</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>T-cell trafficking in the central nervous system</article-title>
<source/>Immunol. Rev.
          <volume>248</volume>
<year>2012</year>
<fpage>216</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="pmid">22725964</pub-id>
</element-citation>
</ref>
<ref id="bib0400">
<label>80</label>
<element-citation id="sbref0400" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ricard</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin</article-title>
<source/>Exp. Dermatol.
          <volume>21</volume>
<year>2012</year>
<fpage>411</fpage>
<lpage>416</lpage>
<pub-id pub-id-type="pmid">22507556</pub-id>
</element-citation>
</ref>
<ref id="bib0405">
<label>81</label>
<element-citation id="sbref0405" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roig</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Expression of the tyrosine kinase discoidin domain receptor 1 (DDR1) in human central nervous system myelin</article-title>
<source/>Brain Res.
          <volume>1336</volume>
<year>2010</year>
<fpage>22</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="pmid">20380825</pub-id>
</element-citation>
</ref>
<ref id="bib0410">
<label>82</label>
<element-citation id="sbref0410" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franco-Pons</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro</article-title>
<source/>J. Mol. Neurosci.
          <volume>38</volume>
<year>2009</year>
<fpage>2</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">18836851</pub-id>
</element-citation>
</ref>
<ref id="bib0415">
<label>83</label>
<element-citation id="sbref0415" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roig</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia</article-title>
<source/>Mol. Psychiatry
          <volume>12</volume>
<year>2007</year>
<fpage>833</fpage>
<lpage>841</lpage>
<pub-id pub-id-type="pmid">17440435</pub-id>
</element-citation>
</ref>
<ref id="bib0420">
<label>84</label>
<element-citation id="sbref0420" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>CD4+CD25+ regulatory T cell depletion modulates anxiety and depression-like behaviors in mice</article-title>
<source/>PLoS One
          <volume>7</volume>
<year>2012</year>
<fpage>1</fpage>
<lpage>11</lpage>
</element-citation>
</ref>
<ref id="bib0425">
<label>85</label>
<element-citation id="sbref0425" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liesz</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke</article-title>
<source/>J. Neurosci.
          <volume>33</volume>
<year>2013</year>
<fpage>17350</fpage>
<lpage>17362</lpage>
<pub-id pub-id-type="pmid">24174668</pub-id>
</element-citation>
</ref>
<ref id="bib0430">
<label>86</label>
<element-citation id="sbref0430" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jun</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>L.F.</given-names>
</name>
</person-group>
<article-title>Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets</article-title>
<source/>Nat. Rev. Drug Discov.
          <volume>10</volume>
<year>2011</year>
<fpage>945</fpage>
<lpage>963</lpage>
<pub-id pub-id-type="pmid">22129992</pub-id>
</element-citation>
</ref>
</ref-list>
<glossary id="glo0005">
<title>Glossary</title>
<def-list>
<def-item>
<term>
<bold>CCN protein family</bold>
</term>
<def>
<p>the CCN family of proteins comprise six members, with the CCN abbreviation deriving from the first letters of the first three family members: <underline>C</underline>YR61 (CCN1), <underline>C</underline>TGF (CCN2), <underline>N</underline>OV (CCN3), WISP1 (CCN4), WISP2 (CCN5), and WISP3 (CCN6). CCN proteins are expressed both within the cell and in the extracellular matrix. They mediate a wide range of fundamental cellular processes including survival, proliferation, differentiation, senescence, adhesion, and migration.</p>
</def>
</def-item>
<def-item>
<term>
<bold>Oligodendrocytes</bold>
</term>
<def>
<p>oligodendrocytes are central nervous system cells, the primary function of which is to provide support and insulation to axons through forming a myelin sheath. In the adult brain, oligodendrocytes develop from oligodendrocyte progenitor cells.</p>
</def>
</def-item>
<def-item>
<term>
<bold>Regulatory T cells</bold>
</term>
<def>
<p>regulatory T cells are a subpopulation of the immune system’s T cell ensemble. They are immunosuppressive and act to ‘dampen’ the activity of effector T cells, thereby helping to maintain tolerance to self-antigens and prevent autoimmune conditions.</p>
</def>
</def-item>
</def-list>
</glossary>
<ack id="ack0005">
<title>Acknowledgements</title>
<p>This work was supported by a grant from the <funding-source id="gs0005">UK Medical Research Council</funding-source> (MR/L010305/1) and partly supported by the <funding-source id="gs0010">Medical Research Foundation</funding-source> (C0439), the <funding-source id="gs0015">Psychiatry Research Trust, and the National Institute for Health Research (NIHR)</funding-source><funding-source id="gs0020">Biomedical Research Centre at South London</funding-source> and <funding-source id="gs0025">Maudsley National Health Service (NHS) Foundation Trust</funding-source> and <funding-source id="gs0030">King’s College London</funding-source>. The funding bodies had no role in the collection or interpretation of the data, or in the decision to submit for publication. The views expressed are those of the authors and are not necessarily those of the NHS, the NIHR, or the Department of Health. For this work, M.F.’s research was supported by an NIHR Clinical Lectureship.</p>
</ack>
</back>
</article>
</pmc-articleset>